Goldman Sachs Group Inc Dexcom Inc Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Dexcom Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 2,493,674 shares of DXCM stock, worth $167 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,493,674
Previous 2,559,062
2.56%
Holding current value
$167 Million
Previous $175 Million
24.56%
% of portfolio
0.03%
Previous 0.03%
Shares
23 transactions
Others Institutions Holding DXCM
# of Institutions
1,108Shares Held
370MCall Options Held
5.32MPut Options Held
5.18M-
Vanguard Group Inc Valley Forge, PA48.3MShares$3.24 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.31 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.9MShares$1.13 Billion0.06% of portfolio
-
Baillie Gifford & CO16.7MShares$1.12 Billion1.14% of portfolio
-
Jennison Associates LLC11.5MShares$772 Million0.6% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $25.9B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...